Nefrologie
01/01/2022
Nefrologie
Nocardia infections in hematopoietic cell transplant recipients : a multicenter international retrospective study of the Infectious Diseases Working Party (IDWP) of the European Society for Blood and Marrow Transplantation (EBMT).
CLINICAL INFECTIOUS DISEASES. 2022dr. Van Praet Jens
01/01/2022
Nefrologie
Longevity and clinical effectiveness of the humoral and cellular responses to SARS-CoV-2 vaccination in hemodialysis patients.
KIDNEY INTERNATIONAL REPORTS. 2022;7(7):1103–7.dr. Van Praet Jens
01/01/2022
Nefrologie
The transfer of vaccine‐generated SARS‐CoV‐2 antibodies into infantile circulation via breastmilk.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS. 2022;dr. Van Praet Jens
01/01/2022
Nefrologie
Acute perimyocarditis in a case of multisystem inflammatory syndrome in adults.
Vol. 49, JOURNAL OF RHEUMATOLOGY. 2022. p. 538–9.dr. Van Praet Jens
01/01/2022
Nefrologie
COVID-19 in adult acute myeloid leukemia patients : a long-term followup study from the European Hematology Association survey (EPICOVIDEHA).
HAEMATOLOGICA. 2022dr. Van Praet Jens
01/01/2022
Nefrologie
Infections caused by hypervirulent Klebsiella pneumoniae in non-endemic countries : three case reports and review of the literature.
ACTA CLINICA BELGICA. 2022dr. Van Praet Jens
01/01/2022
Nefrologie
Outcome of infection with omicron SARS‐CoV‐2 variant in patients with hematological malignancies : an EPICOVIDEHA survey report.
AMERICAN JOURNAL OF HEMATOLOGY. 2022;97(8):E312–7.dr. Van Praet Jens
01/01/2022
Nefrologie
Immune Senescence Markers Predict the Cellular Immune Response to BNT162b2 Vaccination in Hemodialysis Patients.
Open Forum Infectious Diseases. 2022;9(11).dr. Van Praet Jens
01/01/2022
Nefrologie
B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA).
Frontiers in Oncology. 2022;12.dr. Van Praet Jens
01/01/2022
Nefrologie
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from EPICOVIDEHA survey.
Blood. 2022dr. Van Praet Jens
01/01/2022
Nefrologie
Infectious diarrhea after allogeneic hematopoietic cell transplantation assessed by a multiplex polymerase chain reaction assay.
International Journal of Infectious Diseases. 2022;dr. Van Praet Jens
01/01/2022
Nefrologie
“Impact of COVID-19 on the Belgian HIV Epidemic: Slowdown of HIV Transmission and Testing and Adaptation of Care.”
BMC Infect Dis 22. doi:10.1186/s12879-022-07879-1.dr. Van Praet Jens
09/01/2021
Nefrologie
Incidence, risk factors, timing, and outcome of influenza versus COVID-19-associated putative invasive aspergillosis.
Infect Control Hosp Epidemiol. 2021 Sep;42(9):1149-1150. doi: 10.1017/ice.2020.460. Epub 2020 Sep 9.PMID: 32900411 Free PMC article. No abstract available.dr. Van Praet Jensdr. Vandecasteele Stefaandr. Reynders Marijke
05/01/2021
Nefrologie
Clinical characteristics and outcomes of COVID-19 in people living with HIV in Belgium: A multicenter, retrospective cohort.
J Med Virol. 2021 May;93(5):2971-2978. doi: 10.1002/jmv.26828. Epub 2021 Feb 9.PMID: 33506953 Free PMC article.dr. Vandecasteele Stefaan
12/06/2021
Nefrologie
Humoral and Cellular Immunogenicity of the BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine in Nursing Home Residents.
Clin Infect Dis. 2021 Dec 6;73(11):2145-2147. doi: 10.1093/cid/ciab300.PMID: 33825869 Free PMC article. No abstract available.dr. Van Praet Jensdr. Vandecasteele Stefaandr. De Vriese Andr. Reynders Marijke
06/12/2023
Nefrologie
Dynamics of the Cellular and Humoral Immune Response After BNT162b2 Messenger Ribonucleic Acid Coronavirus Disease 2019 (COVID-19) Vaccination in COVID-19-Naive Nursing Home Residents.
J Infect Dis. 2021 Nov 22;224(10):1690-1693. doi: 10.1093/infdis/jiab458.PMID: 34514509dr. Van Praet Jensdr. Vandecasteele Stefaandr. De Vriese Andr. Reynders Marijke
12/01/2022
Nefrologie
Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial.
Lancet Respir Med. 2021 Dec;9(12):1427-1438. doi: 10.1016/S2213-2600(21)00377-5. Epub 2021 Oct 29.PMID: 34756178 Free PMC article. Clinical Trial.dr. Vandecasteele Stefaan
01/02/2022
Nefrologie
A public health value-based healthcare paradigm for HIV.
BMC Health Serv Res. 2022 Jan 2;22(1):13. doi: 10.1186/s12913-021-07371-7.PMID: 34974833 Free PMC article.dr. Vandecasteele Stefaan
06/12/2023
Nefrologie
Chronic Schistosomiasis Presenting with Migrating Pulmonary Manifestation after Recent COVID-19 Infection: HRCT Findings.
J Belg Soc Radiol. 2022 Apr 27;106(1):21. doi: 10.5334/jbsr.2758. eCollection 2022.PMID: 35581982 Free PMC article.dr. Vandecasteele Stefaan
08/09/2022
Nefrologie
Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trial.
Respir Res. 2022 Aug 9;23(1):202. doi: 10.1186/s12931-022-02126-2.PMID: 35945604 Free PMC article. Clinical Trial.dr. Vandecasteele Stefaan
06/05/2020
Nefrologie
IgG Antibody Response to SARS-Co-V-2 Infection and Viral RNA Persistence in Patients on Maintenance Hemodialysis.
Am J Kidney Dis 2020dr. De Vriese Andr. Reynders Marijke
01/01/2022
Nefrologie
Epidemiology of native kidney disease in Flanders: results from the FCGG kidney biopsy registry.
Clin Kidney J 2022; 15: 1361-1372dr. De Vriese An
01/01/2021
Nefrologie
Covid-19 in dialysis: clinical impact, immune response, prevention and treatment.
Kidney Int 2022; 101:883-894dr. De Vriese An
01/01/2021
Nefrologie
Noninvasive diagnosis of PLA2R-associated membranous nephropathy: a validation study.
Clin J Am Soc Nephrol 2021.dr. De Vriese An
01/01/2021
Nefrologie
Longevity and correlation with disease severity of the humoral and cellular response to SARS-CoV-2 infection in hemodialysis patients.
Clin Kidney J 2021; 14: 2446-2448.dr. Van Praet Jensdr. De Vriese Andr. Reynders Marijke
01/01/2021
Nefrologie
Predictors and dynamics of the humoral and cellular immune response to SARS-CoV-2 mRNA vaccines in hemodialysis patients: a multicenter observational study.
J Am Soc Nephrol 2021.dr. Van Praet Jensdr. De Vriese Andr. Reynders Marijke
01/01/2021
Nefrologie
Dynamics of the cellular and humoral immune response after BNT162b2 mRNA Covid-19 vaccination in Covid-19 naive nursing home residents.
J Infect Dis 2021.dr. Van Praet Jensdr. Vandecasteele Stefaandr. De Vriese Andr. Reynders Marijke
01/01/2021
Nefrologie
Therapeutic trials in adult FSGS: lessons learned and the road forward.
Nat Rev Nephrol 2021; 17: 619-630.dr. De Vriese An
01/01/2021
Nefrologie
Humoral and cellular immunogenicity and safety of the BNT162b2 mRNA Covid-19 Vaccine in nursing home residents.
Clin Inf Dis 2021.dr. Van Praet Jensdr. Vandecasteele Stefaandr. De Vriese Andr. Reynders Marijke
01/01/2021
Nefrologie
Safety and efficacy of vitamin K antagonists versus rivaroxaban in hemodialysis patients with atrial fibrillation: a multicenter randomized controlled trial.
J Am Soc Nephrol 2021; 32: 1474-1483.dr. Van Der Meersch Hansdr. De Vriese An
01/01/2021
Nefrologie
A target antigen-based approach to the classification of membranous nephropathy.
Mayo Clin Proc 2021; 96: 577-591.dr. De Vriese An
01/01/2021
Nefrologie
Anticoagulation management in hemodialysis patients with atrial fibrillation: evidence and opinion.
Nephrol Dial Transplant 2021.dr. De Vriese An
01/01/2021
Nefrologie
Incidence, characteristics and outcome of Covid-19 in adult patients on kidney replacement therapy: a region-wide cohort study.
J Am Soc Nephrol 2021; 32: 385-396.dr. De Vriese An
01/01/2021
Nefrologie
PEXIVAS: The end of plasmapheresis for ANCA-associated vasculitis?
Clin J Am Soc Nephrol 2021; 16: 307-309.dr. De Vriese An
06/12/2023
Nefrologie
Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial.
Lancet Respir Med. 2021 Oct 29:S2213-2600(21)00377-5. doi: 10.1016/S2213-2600(21)00377-5. Online ahead of print.dr. Vandecasteele Stefaan
05/01/2021
Nefrologie
Belgian Research on AIDS and HIV Consortium. Clinical haracteristics and outcomes of COVID-19 in people living with HIV in Belgium: A multicenter, retrospective cohort.
J Med Virol. 2021. May;93(5):2971-2978.dr. Vandecasteele Stefaan
09/01/2021
Nefrologie
Incidence, risk factors, timing and outcome of influenza versus Covid-19 associated putative invasive aspergillosis.
Infection Control and Hospital Epidemiology, 2021, Sep;42(9):1149-1150dr. Van Praet Jensdr. Vandecasteele Stefaandr. Reynders Marijke
01/01/2021
Nefrologie
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths.
Sci Immunol. 2021; 6(62):eabl4340.dr. Van Praet Jens
01/01/2021
Nefrologie
X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19.
Sci Immunol. 2021;6(62):eabl4348.dr. Van Praet Jens
01/01/2021
Nefrologie
Nocardia infections in hematopoietic cell transplant recipients: a multicenter international retrospective study of the Infectious Diseases Working Party (IDWP) of the European Society for Blood and Marrow Transplantation (EBMT).
Clin Infect Dis 2021: Online ahead of print.dr. Van Praet Jens
01/01/2021
Nefrologie
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA).
J Hematol Oncol 2021 14(1):168.dr. Van Praet Jens
01/01/2021
Nefrologie
COVID-19-Associated Pulmonary Aspergillosis, March-August 2020.
FungiScope European Confederation of Medical Mycology/The International Society for Human and Animal Mycology Working Group. Emerg Infect Dis 2021;27:1077-1086.dr. Van Praet Jens
01/01/2021
Nefrologie
Hospital mortality in COVID-19 patients in Belgium treated with statins, ACE inhibitors and/or ARBs.
Hum Vaccin Immunother 2021;17:2841-2850.dr. Van Praet Jens
01/01/2020
Nefrologie
Incidence, risk factors, timing and outcome of influenza versus Covid-19 associated putative invasive aspergillosis.
Infection Control and Hospital Epidemiology, 2020dr. Van Praet Jensdr. Vandecasteele Stefaandr. Reynders Marijke
06/12/2023
Nefrologie
Correction to: Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC): A structured summary of a study protocol for a randomised controlled trial.
Trials. 2020 Jun 22;21(1):554. doi: 10.1186/s13063-020-04520-x.dr. Vandecasteele Stefaandr. Peene Isabelle
06/12/2023
Nefrologie
Correction to: Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial.
Trials. 2020 Jun 22;21(1):556. doi: 10.1186/s13063-020-04519-4.dr. Vandecasteele Stefaandr. Peene Isabelle
06/05/2020
Nefrologie
Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC): A structured summary of a study protocol for a randomised controlled trial.
Trials. 2020 Jun 5;21(1):491. doi: 10.1186/s13063-020-04451-7.dr. Vandecasteele Stefaandr. Peene Isabelle
06/12/2023
Nefrologie
Epidemiology of Pneumocystis jirovecii Pneumonia and (Non-)use of Prophylaxis.
Front Cell Infect Microbiol. 2020 May 15;10:224. doi: 10.3389/fcimb.2020.00224.dr. Vandecasteele Stefaandr. Reynders Marijke
06/03/2020
Nefrologie
Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial.
Trials. 2020 Jun 3;21(1):468.dr. Vandecasteele Stefaandr. Peene Isabelle
09/01/2020
Nefrologie
Mycoplasma genitalium acquisition and macrolide resistance after initiation of HIV pre-exposure prophylaxis in men who have sex with men.
Sex Transm Infect. 2020 Sep;96(6):396-398.dr. Van Praet Jensdr. Vandecasteele Stefaandr. Van den Bergh Barbaradr. Reynders Marijke
01/01/2021
Nefrologie
Incidence, characteristics and outcome of Covid-19 in adult patients on kidney replacement therapy: a region-wide cohort study.
J Am Soc Nephrol 2020dr. De Vriese An
01/01/2020
Nefrologie
Standardized Reporting of Monoclonal Immunoglobulin-Associated Renal Diseases: Recommendations from a Mayo Clinic/Renal Pathology Society Working Group.
Kidney Int 2020; 98: 310-313.dr. De Vriese An
06/12/2023
Nefrologie
In Reply to ‘Is SARS-CoV-2 Serology Relevant for Hemodialysis Patients With COVID-19?’
Am J Kidney Dis 2020.dr. De Vriese Andr. Reynders Marijke
01/01/2020
Nefrologie
Mycoplasma genitalium acquisition and macrolide resistance after initiation of HIV pre-exposure prophylaxis in men who have sex with men.
Sex Transm Infect. 2020; 96:396-398dr. Van Praet Jensdr. Vandecasteele Stefaandr. Van den Bergh Barbaradr. Reynders Marijke
06/12/2023
Nefrologie
Prevention of nosocomial COVID-19: Another challenge of the pandemic.
Infect Control Hosp Epidemiol. 2020 Apr 23:1-2dr. Van Praet Jens
01/01/2020
Nefrologie
Impact of solid cancer on in-hospital mortality overall and among different subgroups of patients with COVID-19: a nationwide, population-based analysis.
ESMO Open. 2020 doi: 10.1136/esmoopen-2020-000947dr. Van Praet Jens
01/01/2020
Nefrologie
Low-dose hydroxychloroquine therapy and mortality in hospitalised patients with COVID-19: a nationwide observational study of 8075 participants.
Int J Antimicrob Agents. 2020 doi: 10.1016/j.ijantimicag.2020.106144.dr. Van Praet Jens
09/09/2020
Nefrologie
Incidence, risk factors, timing and outcome of influenza versus Covid-19 associated putative invasive aspergillosis.
Infect Control Hosp Epidemiol. 2020 Sep 9:1-7. doi: 10.1017/ice.2020.460.dr. Van Praet Jensdr. Vandecasteele Stefaandr. Reynders Marijke
01/01/2020
Nefrologie
Comparison of four commercial SARS-CoV-2 IgG immuno-assays in RT-PCR negative patients with suspect CT findings.
Infection. 2020 doi: 10.1007/s15010-020-01523-3.dr. Van Praet Jensdr. Reynders Marijke
01/01/2020
Nefrologie
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.
Science. 2020. doi: 10.1126/science.abd4570.dr. Van Praet Jens
01/01/2020
Nefrologie
Time between Symptom Onset, Hospitalisation and Recovery or Death: Statistical Analysis of Belgian COVID-19 Patients.
Int J Environ Res Public Health. 2020 doi: 10.3390/ijerph17207560.dr. Van Praet Jens
01/01/2020
Nefrologie
Successful Outcome of Disseminated Fusarium musae Fungemia with Skin Localization Treated with Liposomal Amphotericin B and Voriconazole in a Patient with Acute Myeloid Leukemia.
Mycopathologia. 2020 doi: 10.1007/s11046-020-00499-wdr. Nulens Ericdr. Van Praet Jensdr. Lodewyck Tomdr. Reynders Marijke
10/01/2019
Nefrologie
A case of a surgical-site infection with Staphylococcus condimenti.
Infection. 2019 Oct;47(5):853-856. doi: 10.1007/s15010-019-01276-8. Epub 2019 Apr 5.dr. Tajdar Mercedehdr. Nulens Ericdr. Van Praet Jensdr. Vandecasteele Stefaandr. Reynders Marijke
10/03/2019
Nefrologie
Adrenal insufficiency, be aware of drug interactions!
Endocrinol Diabetes Metab Case Rep. 2019 Oct 3;2019. pii: EDM190062. doi: 10.1530/EDM-19-0062. [Epub ahead of print]dr. Van den Bruel Annickdr. Vandecasteele Stefaan
06/12/2023
Nefrologie
Textiloma-Induced 1,25-Dihydroxyvitamin D-Mediated Hypercalcemia: A Case Report and Literature Study.
J Endocr Soc. 2019 Aug 27;3(11):2158-2164. doi: 10.1210/js.2019-00206. eCollection 2019 Nov 1.dr. Van den Bruel Annickdr. Vandecasteele Stefaandr. Van Cauwenberge SebastiaanNefrologie
Other consequences from monoclonal immunoglobulins/fragments. Membranoproliferative glomerulonephritis and acquired Fanconi syndrome.
In: The Oxford Textbook of Clinical Nephrology.dr. De Vriese AnNefrologie
Membranoproliferative glomerulonephritis and cryoglobulinemic glomerulonephritis.
In: Comprehensive Clinical Nephrology, 6th Edition. Edited by John Feehally, Rick Johnson, Jürgen Floege, Marcello Tonelli.dr. De Vriese AnNefrologie
The approach to the patient with glomerular disease.
In: Scientific American Nephrology Dialysis and Transplantation.dr. De Vriese AnNefrologie
Membranous nephropathy.
In: National Kidney Foundation’s Primer on Kidney Diseases, 7th Edition. Edited by Scott Gilbert, Daniel Weiner, Andrew Bomback, Mark Perazella, Marcello Tonelli, pp. 188-197. ISBN: 978-0-323-47794-9dr. De Vriese AnNefrologie
Membranoproliferative glomerulonephritis.
In: Current Progress in Nephrology. Edited by Claudio Ponticelli and R Kasi Visweswaran, pp. 57-78. ISBN: 978-93-83989-19-5dr. De Vriese AnNefrologie
Glomerular diseases.
In: Cecil Essentials of Medicine. Edited by IJ Benjamin, pp 314-328. ISBN: 978-0-323-29617-5dr. De Vriese AnNefrologie
Indications to start kidney replacement therapy.
In: Management of acute kidney problems. Edited by A Jorres, C Ronco and Kellum, pp 471-479. ISBN: 978-3-540-69413-7dr. De Vriese AnNefrologie
The peritoneal microcirculation in peritoneal dialysis.
In: Textbook of Peritoneal Dialysis, 3rd Edition. Edited by R Gokal, R Khanna, RT Krediet and KD Nolph, pp 51-71. ISBN 978-0-387-78939-2dr. De Vriese An
01/01/2002
Nefrologie
Connexin-mimetic peptides: Influence on nitric oxide synthase- and cyclooxygenase-independent renal vasodilatation, basal renal blood flow and blood pressure in the rat.
In: EDHF 2002. Edited by PM VANHOUTTE, pp 78-86. ISBN 0-415-30853-4dr. De Vriese An
01/01/2000
Nefrologie
Folate restores the NO synthase- and cyclooxygenase-resistant renal vasodilator response to acetylcholine in diabetes.
In: EDHF 2000. Edited by PM VANHOUTTE, pp 360-369. ISBN 0-415-26904-0dr. De Vriese AnNefrologie
Factors influencing the progression of diabetic nephropathy.
In: Diabetic Nephropathy. Edited by J BONER, M COOPER, pp 75-96. ISBN 1-84184-076-9dr. De Vriese An
01/01/1999
Nefrologie
Acute renal failure in natural disasters.
In: Acute renal failure: a companion to Brenner & Rector’s the kidney. Edited by B MOLITORIS, W FINN, pp 236-245. ISBN 0-7216-9174-9dr. De Vriese An
01/01/1999
Nefrologie
Continuous renal replacement therapies in sepsis: do they matter?
In: Yearbook of Intensive Care and Emergency Medicine 1999, Edited by JL VINCENT, pp 611-620. ISSN 0942-5381.dr. De Vriese An
01/01/1992
Nefrologie
Influence of vasoactive intestinal polypeptide and NG-nitro-L-argininemethylester on cholinergic neurotransmission in the rat gastric fundus.
Eur J Pharmacol 1992; 221: 235-242.dr. De Vriese An
01/01/1995
Nefrologie
Carbamazepine hypersensitivity syndrome: report of 4 cases and review of the literature.
Medicine 1995; 74: 144-151dr. De Vriese An
01/01/1997
Nefrologie
Severe acute renal failure due to bromate intoxication: report of a case and discussion of management guidelines based on a review of the literature.
Nephrol Dial Transplant 1997; 12: 204-209.dr. De Vriese An
01/01/1997
Nefrologie
Pitfalls in the diagnosis of hypereosinophilic syndrome: a report of two cases.
J Int Med 1997; 241: 165-170.dr. De Vriese An
01/01/1998
Nefrologie
Rifampicin-associated acute renal failure: pathophysiologic, immunologic and clinical features.
Am J Kidney Dis 1998; 31: 108-115.dr. De Vriese An
01/01/1997
Nefrologie
Fundus fluorescein angiography in hypertensive renal failure.
Graefe Arch Clin Exp Ophtalmol 1997; 235: 749-754.dr. De Vriese An
01/01/1998
Nefrologie
Continuous renal replacement therapies in sepsis: where are the data ?
Nephrol Dial Transplant 1998; 13: 1362-1364.dr. De Vriese An
01/01/1998
Nefrologie
Mild to moderate hyperhomocysteinaemia in cardiovascular disease.
Acta Cardiologica 1998; 53: 337-344.dr. De Vriese An
01/01/1999
Nefrologie
Cytokine removal during continuous hemofiltration in septic patients.
J Am Soc Nephrol 1999; 10: 846-853.dr. De Vriese An
01/01/1999
Nefrologie
Can inflammatory mediators be removed efficiently by continuous renal replacement techniques?
Intensive Care Med 1999; 25: 903-910.dr. De Vriese An
01/01/1999
Nefrologie
Evidence based therapy of acute renal failure.
Acta Clin Belg 1999; 54: 263-273.dr. De Vriese An
01/01/1999
Nefrologie
The role of selectins in glomerular leukocyte adhesion in rat anti-glomerular basement membrane glomerulonephritis.
J Am Soc Nephrol 1999; 10: 2510-2517.dr. De Vriese An
01/01/2000
Nefrologie
The role of dialyzer biocompatibility in acute renal failure.
Blood Purif 2000; 18: 1-12.dr. De Vriese An
01/01/2000
Nefrologie
Off-line analysis of red blood cell velocity in renal arterioles.
J Vasc Res 2000; 37: 26-31.dr. De Vriese An
01/01/2000
Nefrologie
Endothelial dysfunction in diabetes.
Br J Pharmacol 2000; 130: 963-974.dr. De Vriese An
01/01/2000
Nefrologie
The impaired renal vasodilator response attributed to endothelium-derived hyperpolarizing factor in streptozotocin-induced diabetic rats is restored by 5-methyltetrahydrofolate.
Diabetologia 2000; 43: 1116-1125.dr. De Vriese An
01/01/2001
Nefrologie
Intravital microscopy: an integrated evaluation of peritoneal function and structure.
Nephrol Dial Transplant 2001; 16: 657-660.dr. De Vriese An
01/01/2001
Nefrologie
Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes.
J Am Soc Nephrol 2001; 12: 993-1000.dr. De Vriese An
01/01/2001
Nefrologie
Evidence-based treatment of hypertension in diabetes type 2.
Acta Clin Belg 2001; 56: 96-102.dr. De Vriese An
01/01/2001
Nefrologie
Diabetes-induced renal microvascular dysfunction in the hydronephrotic kidney: role of nitric oxide.
Kidney Int 2001; 60: 202-210.dr. De Vriese An
01/01/2001
Nefrologie
Vascular endothelial growth factor is essential for hyperglycemia-induced structural and functional alterations of the peritoneal membrane.
J Am Soc Nephrol 2001; 12: 1734-1741.dr. De Vriese An
01/01/2001
Nefrologie
Adsorption techniques and the use of sorbents.
Contrib Nephrol 2001; 133: 140-153.dr. De Vriese An
01/01/2001
Nefrologie
Neoangiogenesis in the peritoneal membrane: does it play a role in ultrafiltration failure ?
Nephrol Dial Transplant 2001; 16: 2143-2145.dr. De Vriese An
01/01/2001
Nefrologie
Glucotoxicity of the peritoneal membrane: the case for VEGF.
Nephrol Dial Transplant 2001; 16: 2299-2302dr. De Vriese An
01/01/2002
Nefrologie
Effects of connexin-mimetic peptides on nitric oxide synthase- and cyclooxygenase-independent renal vasodilatation, basal renal blood flow and blood pressure.
Kidney Int 2002; 61: 177-185.dr. De Vriese An
01/01/2002
Nefrologie
Hemodynamic effects of conventional and new peritoneal dialysis solutions on the microcirculation of the rat peritoneal membrane. Role of acidity, buffer choice, glucose concentration and glucose degradation products.
J Am Soc Nephrol 2002; 13: 480-489.dr. De Vriese An
01/01/2001
Nefrologie
Non anticoagulant effects of heparin: implications for animal models of peritoneal dialysis.
Perit Dial Int 2001; 21 (Suppl 3): S354-S356.dr. De Vriese An
01/01/2001
Nefrologie
What happens to the peritoneal membrane in long-term peritoneal dialysis ?
Perit Dial Int 2001; 21 (Suppl 3): S3-S12.dr. De Vriese An
01/01/2002
Nefrologie
Is folate a promising agent in the prevention and treatment of cardiovascular disease in patients with renal failure?
Kidney Int 2002; 61: 1199-1209.dr. De Vriese An
01/01/2002
Nefrologie
Why are homocysteine levels elevated in renal failure? A metabolic approach.
J Lab Clin Med 2002; 139: 262-268.dr. De Vriese An
01/01/2002
Nefrologie
Experimental diabetes induces functional and structural changes in the peritoneum.
Kidney Int 2002; 62: 668-678.dr. De Vriese An
01/01/2002
Nefrologie
Compensatory glomerular hypertrophy following unilateral nephrectomy is strictly VEGF dependent.
Am J Physiol Endocrinol Metab 2002; 283: E362-366.dr. De Vriese An
01/01/2002
Nefrologie
Comparison of the radioiodinated serum albumin (RISA) dilution technique with direct volumetric measurements in animal models of peritoneal dialysis.
Perit Dial Int 2002; 22: 316-322.dr. De Vriese An
01/01/2002
Nefrologie
Amelioration of long-term renal changes in obese type 2 diabetic mice with a neutralizing vascular endothelial growth factor (VEGF)-antibody.
Diabetes 2002; 51: 3090-3094.dr. De Vriese An
01/01/2002
Nefrologie
Molecular imaging of early events in the development of the diabetic cardiomyopathy.
Amino Acids 2002; 23: 331-336.dr. De Vriese An
01/01/2002
Nefrologie
Interesting news in peritoneal dialysis.
Nephron 2002; 92: 763-771.dr. De Vriese An
01/01/2002
Nefrologie
The effects of heparin administration in an animal model of chronic dialysate exposure.
Perit Dial Int 2002; 22: 566-572.dr. De Vriese An
01/01/2002
Nefrologie
Increased leukocyte rolling in newly formed mesenteric vessels in the rat peritoneal membrane during peritoneal dialysis.
Perit Dial Int 2002; 22: 655-662.dr. De Vriese An
01/01/2003
Nefrologie
The statement that folate supraphysiological levels in uremic patients do not cause harm should not go unchallenged.
Kidney Int 2003; 63 :771-773.dr. De Vriese An
01/01/2003
Nefrologie
Recent concepts in the molecular biology of the peritoneal membrane – Implications for more biocompatible dialysis solutions.
Blood Purif 2003; 21: 14-23.dr. De Vriese An
01/01/2003
Nefrologie
Prevention and treatment of acute renal failure in sepsis.
J Am Soc Nephrol 2003; 14: 792-805dr. De Vriese An
01/01/2003
Nefrologie
Renal angiomyolipoma in association with pulmonary lymphangioleiomyomatosis.
Am J Kidney Dis 2003; 41: 877-883.dr. De Vriese An
01/01/2003
Nefrologie
Effects of conventional and new peritoneal dialysis solutions on leukocyte recruitment in the microcirculation of the rat peritoneal membrane.
J Am Soc Nephrol 2003; 14: 1296-1306.dr. De Vriese An
01/01/2003
Nefrologie
Extensive acronecrosis as a manifestation of mixed cryoglobulinemia.
Acta Clin Belg 2003; 58: 58-61.dr. De Vriese An
01/01/2003
Nefrologie
Inhibition of AGE-RAGE interaction prevents hyperglycemia-induced fibrosis of the peritoneal membrane.
J Am Soc Nephrol 2003; 14: 2109-2118.dr. De Vriese An
01/01/2003
Nefrologie
The emerging role of VEGF in diabetic kidney disease.
Nephrol Dial Transplant 2003; 18: 1427-1430.dr. De Vriese An
01/01/2003
Nefrologie
Intravital videomicroscopy in peritoneal dialysis research.
Nefrologia 2003; 23 Suppl 3: 28-31.dr. De Vriese An
01/01/2003
Nefrologie
Antibiotic administration in an animal model of chronic dialysate exposure.
Perit Dial Int 2003; 23: 331-338.dr. De Vriese An
01/01/2003
Nefrologie
Creatine-supplementation decreases homocysteine in an animal model of uremia.
Kidney Int 2003; 64: 1331-1337.dr. De Vriese An
01/01/2003
Nefrologie
Effect of dialyzer membrane pore size on plasma homocysteine levels in hemodialysis patients.
Nephrol Dial Transplant 2003; 18: 2596-2600.dr. De Vriese An
01/01/2003
Nefrologie
Pharmacologic treatment of acute renal failure in sepsis.
Curr Opin Crit Care 2003; 9: 474-480.dr. De Vriese An
01/01/2003
Nefrologie
Prevention and nondialytic treatment of acute renal failure.
Curr Opin Crit Care 2003; 9: 481-490.dr. De Vriese An
01/01/2004
Nefrologie
Long-term renal changes in the Goto-Kakizaki rat, a model of lean type 2 diabetes.
Nephrol Dial Transplant 2004; 19: 1092-1097.dr. De Vriese An
01/01/2004
Nefrologie
Vascular hyporesponsiveness in the mesenteric artery of anaesthetized rats with cirrhosis and portal hypertension: an in-vivo study.
Eur J Gastroenterol Hepatol 2004; 16: 139-145.dr. De Vriese An
01/01/2004
Nefrologie
Systemic and splanchnic haemodynamic effects of sildenafil in an in vivo animal model of cirrhosis: support for a risk in cirrhotic patients.
Liver Int 2004; 24: 63-68.dr. De Vriese An
01/01/2004
Nefrologie
Endothelium-derived hyperpolarizing factor – mediated renal vasodilatory response is impaired during acute and chronic hyperhomocysteinemia.
Circulation 2004; 109: 2331-2336.dr. De Vriese An
01/01/2004
Nefrologie
The effects of peritoneal dialysate solutions on peritoneal host defense.
Perit Dial Int 2004; 24: 123-138.dr. De Vriese An
01/01/2004
Nefrologie
Prohepcidin accumulates in renal insufficiency.
Clin Chem Lab Med 2004; 42: 387-389.dr. De Vriese An
01/01/2004
Nefrologie
The role of vascular endothelial growth factor in renal pathophysiology.
Kidney Int 2004; 65: 2003-2017.dr. De Vriese An
01/01/2004
Nefrologie
Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane.
Kidney Int 2004; 66: 1257-1265.dr. De Vriese An
01/01/2005
Nefrologie
Analytical and biochemical aspects associated with supraphysiological creatine intake.
Clin Chim Acta 2005; 351: 217-219.dr. De Vriese An
01/01/2004
Nefrologie
Creatine supplementation does not decrease total plasma homocysteine in chronic hemodialysis patients.
Kidney Int 2004; 66: 2422-2428.dr. De Vriese An
01/01/2004
Nefrologie
From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines.
Endocrine Rev 2004; 25: 971-1010.dr. De Vriese An
01/01/2005
Nefrologie
Cytochrome P450-2C11 mRNA is not expressed in endothelial cells dissected from rat renal arterioles.
Nephron Physiol 2005; 99: 43-49.dr. De Vriese An
01/01/2005
Nefrologie
Inhibition of vascular endothelial growth factor (VEGF) does not affect early renal changes in a rat model of lean type 2 diabetes.
Horm Metab Res 2005; 37: 21-25.dr. De Vriese An
01/01/2004
Nefrologie
The role of hyperhomocysteinemia in relation to nitric oxide (NO) and endothelium-derived hyperpolarizing factor (EDHF)-mediated vasodilatation.
Cell Mol Biol 2004; 50: 911-916.dr. De Vriese An
01/01/2005
Nefrologie
The John F. Maher recipient lecture 2004: RAGE in the peritoneum.
Perit Dial Int 2005; 25: 8-11.dr. De Vriese An
01/01/2005
Nefrologie
Animal models in peritoneal dialysis research: a need for consensus.
Perit Dial Int 2005; 25: 16-24.dr. De Vriese An
01/01/2005
Nefrologie
Benefits of switching from a conventional to a low-GDP bicarbonate/lactate-buffered peritoneal dialysis solution in a rat model.
Kidney Int 2005; 76: 1559-1565.dr. De Vriese An
01/01/2005
Nefrologie
Immunopathological changes in a uraemic rat model for peritoneal dialysis.
Nephrol Dial Transplant 2005; 20: 1350-1361.dr. De Vriese An
01/01/2005
Nefrologie
Pathophysiological role of vascular endothelial growth factor in the remnant kidney.
Nephron Exp Nephrol 2005; 101: e9-15.dr. De Vriese An
01/01/2005
Nefrologie
Effects of new peritoneal dialysis solutions on leukocyte recruitment in the rat peritoneal membrane.
Nephron Exp Nephrol 2005; 101: e139-e145.dr. De Vriese An
01/01/2005
Nefrologie
Management of therapy-resistant systemic lupus erythematosus with rituximab: report of a case and review of the literature.
Acta Clin Belg 2005; 60: 102-105.dr. De Vriese An
01/01/2006
Nefrologie
A neutralizing VEGF antibody prevents glomerular hypertrophy in a model of obese type 2 diabetes, the Zucker diabetic fatty rat.
Nephrol Dial Transplant 2006; 21: 324-329.dr. De Vriese An
01/01/2005
Nefrologie
A case of secondary frosted branch angiitis in Behçet’s disease.
Bull Soc Belg Ophtalmol 2005; 298: 41-44.dr. De Vriese An
01/01/2006
Nefrologie
Activation of genes inducing cell-cycle arrest and of increased DNA repair in the hearts of rats with early streptozotocin-induced diabetes mellitus.
Med Sci Monit 2006; 12: BR68-74.dr. De Vriese An
01/01/2006
Nefrologie
Linezolid-induced inhibition of mitochondrial protein synthesis.
Clin Inf Dis 2006; 42: 1111-1117.dr. De Vriese An
01/01/2006
Nefrologie
What did we learn from animal models in peritoneal dialysis ?
Contrib Nephrol 2006; 150: 70-76.dr. De Vriese An
01/01/2006
Nefrologie
Effects of peritoneal dialysis on the vascular bed of the peritoneal membrane.
Contrib Nephrol 2006; 150: 84-89.dr. De Vriese An
01/01/2006
Nefrologie
RAGE-induced myofibroblast transdifferentiation of mesothelial cells contributes to peritoneal fibrosis in uremia.
Nephrol Dial Transplant 2006; 21: 2549-2555.dr. De Vriese An
01/01/2006
Nefrologie
Increased angiogenesis and permeability in the mesenteric microvasculature of rats with cirrhosis and portal hypertension: an in vivo study.
Liver Int 2006; 26: 889-898.dr. De Vriese An
01/01/2007
Nefrologie
Diet-induced hyperhomocysteinemia does not lead to large gene expression differences in rat aorta.
Atherosclerosis 2007; 193: 452-454.dr. De Vriese An
01/01/2006
Nefrologie
Current recommendations for diagnosis and management of polyoma BK virus nephropathy in renal transplant recipients.
Nephrol Dial Transplant 2006; 21: 3364-3367.dr. De Vriese An
01/01/2007
Nefrologie
Steroid-resistant sarcoidosis: is antagonism of TNF-α the answer ?
Clin Sci 2007; 112: 281-289.dr. De Vriese An
01/01/2007
Nefrologie
Decreased leukocyte recruitment in the mesenteric microcirculation of rats with cirrhosis is partially restored by treatment with peginterferon: An in vivo study.
J Hepatol 2007; 46: 804-815.dr. De Vriese An
01/01/2007
Nefrologie
Prevention of contrast-induced nephropathy: a critical review.
Curr Opinion Nephrol Hypertens 2007; 16: 336-347.dr. De Vriese An
01/01/2007
Nefrologie
Renal side effects of anti-VEGF therapy in man: a new test system.
Nephrol Dial Transplant 2007, 22: 2778-80.dr. De Vriese An
01/01/2007
Nefrologie
Novel insights in the treatment of diabetic nephropathy.
Acta Clin Belg 2007; 62: 278-290.dr. De Vriese An
01/01/2008
Nefrologie
Guanidinocompounds after creatine supplementation in renal failure patients and their relation to inflammatory status.
Nephrol Dial Transplant 2008; 23: 1330-1335.dr. De Vriese An
01/01/2008
Nefrologie
Oral vitamin C administration increases lipid peroxidation in hemodialysis patients.
Nephron Clin Pract 2008; 108: c28-c34.dr. De Vriese An
01/01/2008
Nefrologie
Autologous transplantation of bone marrow mononuclear cells for limb ischemia in a Caucasian population with atherosclerosis obliterans.
J Intern Med 2008; 263: 395-403.dr. De Vriese An
01/01/2008
Nefrologie
Cellular therapy for critical limb ischemia. Author’s reply.
J Intern Med 2008; 264: 290.dr. De Vriese An
01/01/2009
Nefrologie
Comparison of the prognostic value of dipyridamole and dobutamine myocardial perfusion scintigraphy in end-stage renal disease.
Kidney Int 2009; 76: 428-436.dr. De Vriese An
01/01/2009
Nefrologie
Staphylococcus aureus infections in dialysis: what a nephrologist should know.
Clin J Am Soc Nephrol 2009; 4: 1388-1400.dr. De Vriese An
01/01/2010
Nefrologie
Diffuse alveolar bleeding caused by everolimus.
Chest 2010; 137: 456-459.dr. De Vriese An
01/01/2010
Nefrologie
Recent changes in vancomycin use in renal failure.
Kidney Int 2010; 77: 760-764.dr. De Vriese An
01/01/2011
Nefrologie
Successful treatment of renal AA amyloidosis in familial Mediterranean fever with pegylated -2a interferon.
Clin Nephrol 2011; 75 (Suppl 1): S1-S3.dr. De Vriese An
01/01/2011
Nefrologie
Vancomycin dosing in patients on intermittent hemodialysis.
Semin Dial 2011; 24: 50-55.dr. De Vriese An
01/01/2011
Nefrologie
Fluctuations of haemoglobinaemia in chronic hemodialysis patients.
Acta Clin Belg 2011; 66: 123-128.dr. De Vriese An
01/01/2011
Nefrologie
Implementation of a dose calculator for vancomycin to achieve target through levels of 15-20 mg:ml in persons undergoing hemodialysis.
Clin Inf Dis 2011; 53: 124-129.dr. De Vriese An
01/01/2012
Nefrologie
Should we screen for coronary artery disease in asymptomatic chronic hemodialysis patients ?
Kidney Int 2012; 81: 143-151.dr. De Vriese An
01/01/2012
Nefrologie
Reversion of cerebral artery stenoses due to tuberculomas with TNF-alpha antibodies.
Clin Neurol Neurosurg 2012; 114: 1016-8.dr. De Vriese An
01/01/2013
Nefrologie
The pharmacokinetics and pharmacodynamics of vancomycin in clinical practice: evidence and uncertainties.
J Antimicrob Chemother 2013; 68: 743-8.dr. De Vriese An
01/01/2013
Nefrologie
Global protein and histone arginine methylation are affected in a tissue-specific manner in a rat model of diet-induced hyperhomocysteinemia.
Biochim Biophys Acta 2013; 1832: 1708-14.dr. De Vriese An
01/01/2013
Nefrologie
Protein-bound uremic toxins stimulate crosstalk between leukocytes and vessel wall.
J Am Soc Nephrol 2013; 24: 1981-94.dr. De Vriese An
01/01/2014
Nefrologie
Vitamin K2 Supplementation in Hemodialysis Patients: a Randomized Dosefinding Study.
Nephrol Dial Transplant 2014; 29: 1385-90.dr. De Vriese An
01/01/2013
Nefrologie
Cystatin C versus creatinine for kidney function-based risk.
N Engl J Med 2013; 369: 2458-9.dr. De Vriese An
01/01/2014
Nefrologie
Vancomycin: the tale of the vanquisher and the Pyrrhic victory.
Perit Dial Int 2014; 34: 154-61.dr. De Vriese An
01/01/2015
Nefrologie
Hemodialysis catheter design and catheter performance: a randomized controlled trial.
Am J Kidney Dis 2014; 64: 902-8. Erratum in Am J Kidney Dis 2015; 65: 810.dr. De Vriese An
01/01/2014
Nefrologie
A bone scan, no mistake!
J Clin Endocrinol Metab 2014; 99: 4447-8.dr. De Vriese An
01/01/2015
Nefrologie
Dose finding of rivaroxaban in hemodialysis patients.
Am J Kidney Dis 2015; 66: 91-8.dr. De Vriese An
01/01/2015
Nefrologie
High homocysteine induces betaine depletion.
Biosci Rep 2015; 35: pii:e00222.dr. De Vriese An
01/01/2015
Nefrologie
C4d as a diagnostic tool in the diagnosis of proliferative glomerulonephritis.
J Am Soc Nephrol 2015;26:2852-2859.dr. De Vriese An
01/01/2015
Nefrologie
Biomarkers in glomerular diseases: putting the cart before the wheel?
Nephrol Dial Transplant 2015; 30: 885-890.dr. De Vriese An
01/01/2015
Nefrologie
Opponent’s comments.
Nephrol Dial Transplant 2015; 30: 898-899.dr. De Vriese An
01/01/2015
Nefrologie
In reply to “Hemodialysis catheters: which design is more cost-effective? And “Use of an uncensored primary outcome in a catheter design trial”.
Am J Kidney Dis 2015; 66: 171.dr. De Vriese An
01/01/2015
Nefrologie
Glomerular disease caused by dysregulation of the complement alternative pathway: an etiologic approach.
J Am Soc Nephrol 2015; 26: 2917-2929.dr. De Vriese An
01/01/2016
Nefrologie
C3 glomerulonephritis and autoimmune disease: more than a fortuitous association?
J Nephrol 2016; 29: 203-9.dr. De Vriese An
01/01/2016
Nefrologie
Mayo Clinic/ Renal Pathology Society Consensus Report on Pathologic Classification, Diagnosis, and Reporting of Glomerulonephritis.
J Am Soc Nephrol 2016; 27: 1278-87.dr. De Vriese An
01/01/2016
Nefrologie
Diagnosis of complement alternative pathway disorders.
Kidney Int 2016; 89: 278-288.dr. De Vriese An
01/01/2016
Nefrologie
The effects of vitamin K supplementation and vitamin K antagonists on progression of vascular calcification: ongoing randomized controlled trials.
Clin Kidney J 2016; 9: 273-279.dr. De Vriese An
01/01/2016
Nefrologie
The atrial fibrillation conundrum in dialysis patients.
Am Heart J 2016; 174: 111-119.dr. De Vriese An
01/01/2016
Nefrologie
Temporal IgG subtype changes in recurrent idiopathic membranous nephropathy.
Am J Transplant 2016; 16: 2964-72.dr. De Vriese An
01/01/2023
Nefrologie
A proposal for a serology-driven approach to membranous nephropathy.
J Am Soc Nephrol 2017;28:421-430.dr. De Vriese An
01/01/2016
Nefrologie
Vitamin K antagonists for stroke prevention in hemodialysis patients with atrial fibrillation: a meta-analysis.
Am Heart J 2016; 184: 37-46.dr. De Vriese An
01/01/2017
Nefrologie
Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference.
Kidney Int 2017;91:539-551.dr. De Vriese An
01/01/2017
Nefrologie
Fibromuscular dysplasia: results of a multicenter study in Flanders.
Vasa 2017;46:211-218.dr. De Vriese An
01/01/2017
Nefrologie
Proposal for Standardized Grading of Chronic Changes in Native Kidney Biopsy Specimens.
Kidney Int 2017;91:787-789.dr. De Vriese An
01/01/2017
Nefrologie
Complement activation in pauci-immune necrotizing and crescentic glomerulonephritis: Results of a proteomic analysis.
Nephrol Dial Transplant 2017;32(suppl_1):i139-i145.dr. De Vriese An
01/01/2017
Nefrologie
What are we missing in the clinical trials of focal segmental glomerulosclerosis?
Nephrol Dial Transplant 2017;32(suppl_1):i14-i21.dr. De Vriese An
01/01/2017
Nefrologie
Should statins be banned from dialysis?
J Am Soc Nephrol 2017;28:1675-1676.dr. De Vriese An
01/01/2017
Nefrologie
Familial antiglomerular basement membrane disease in zero human leukocyte antigen mismatch siblings.
Clin Nephrol 2017;88:277-283.dr. De Vriese An
01/01/2017
Nefrologie
Interstitial immunostaining and renal outcomes in anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
Am J Nephrol 2017;46:231-238.dr. De Vriese An
01/01/2017
Nefrologie
The incidence of primary versus secondary focal and segmental glomerulosclerosis: a clinicopathological study.
Mayo Clin Proc 2017;92:1772-1781.dr. De Vriese An
01/01/2018
Nefrologie
Differentiating primary, genetic and secondary FSGS in adults: a clinicopathologic approach.
J Am Soc Nephrol 2018; 29: 759-774.dr. De Vriese An
01/01/2018
Nefrologie
Measurement of pulse wave velocity, augmentation index and central pulse pressure in atrial fibrillation: a proof of concept study.
J Am Soc Hypertens 2018; 12: 627-632.dr. De Vriese An
01/01/2018
Nefrologie
C3 glomerulopathy: Ten years’ experience at the Mayo Clinic.
Mayo Clin Proc 2018; 93: 991-1008.dr. De Vriese An
01/01/2019
Nefrologie
Non-invasive diagnosis of primary membranous nephropathy using Phospholipase A2 receptor antibodies.
Kidney Int 2019dr. De Vriese An
01/01/2020
Nefrologie
Evaluation of vitamin K status and rationale for vitamin K supplementation in dialysis patients.
Nephrol Dial Transplant 2019.dr. De Vriese AnGeen podcAZts gevonden...
Geen media gevonden...
